Recent Advances in Immune Checkpoint Inhibitors for Triple-Negative Breast Cancer

Chiara Corti,1– 4 Beyza Koca,1,2 Tasnim Rahman,1,2 Elizabeth A Mittendorf,1,2,5 Sara M Tolaney1,2,6 1Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA; 2Harvard Medical School, Boston, MA, USA; 3Division of New Drugs and Early Drug Development for Innovative Therapies, Euro...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Corti C, Koca B, Rahman T, Mittendorf EA, Tolaney SM
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2025-04-01
Serie:ImmunoTargets and Therapy
Soggetti:
immunotherapy
precision medicine
biomarker
drug development
breast cancer
Accesso online:https://www.dovepress.com/recent-advances-in-immune-checkpoint-inhibitors-for-triple-negative-br-peer-reviewed-fulltext-article-ITT
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi